PFKFB4 silencing increases Fru-2,6-P2 levels in prostate cancer cells, suggesting that it mainly functions as a fructose-2,6-bisphosphatase in these particular cells, diverting glucose 6-phosphate toward the PPP (169). Here, PFKFB3 is linked to prostate carcinoma.